Loading...
A feasibility study showing [68]Ga-citrate PET detects prostate cancer
PURPOSE: The management of advanced or recurrent prostate cancer is limited in part by the lack of effective imaging agents. Metabolic changes in prostate cancer have previously been exploited for imaging, culminating in the recent US-FDA approval of [11]C-choline for the detection of subclinical re...
Na minha lista:
| Udgivet i: | Mol Imaging Biol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6430569/ https://ncbi.nlm.nih.gov/pubmed/27184068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-016-0966-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|